NAVAMEDIC (NAVA.OL) Stock Analyst Earnings Estimates
OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 382.135M 37.26% | 511.997M 33.98% | 531.436M 3.80% | 583.57M 9.81% | 648.98M 11.21% | 718.08M 10.65% | 826.8M 15.14% | 1.148B 38.85% | 1.205B 4.97% | |
| EBITDA YoY % growth | 51.686M 183.68% | 51.567M -0.23% | 72.137M 39.89% | 54.06M -25.06% | 73.44M 35.85% | 90.78M 23.61% | 114.39M 26.01% | N/A | N/A | |
| EBIT YoY % growth | 44.444M 286.47% | 39.641M -10.81% | 31.795M -19.79% | 38.76M 21.91% | 58.14M 50.00% | 75.48M 29.82% | 91.421M 21.12% | 164.35M 79.77% | 172.73M 5.10% | |
| Operating Margin | 11.63% | 7.74% | 5.98% | 6.64% | 8.96% | 10.51% | 11.06% | 14.32% | 14.33% | |
| EPS YoY % growth | N/A 1,856.25% | N/A -43.13% | N/A 44.94% | 0.74 -43.80% | 2.52 240.69% | 3.69 46.36% | 3.86 4.57% | N/A | N/A |
All data in NOK
| Q2 / 25 | Q3 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.61 -46.60% | 0.61 -14.29% |
| Revenue Q2Q % growth | 147.9M -5.38% | 145.86M 18.53% |
| EBITDA Q2Q % growth | 14.79M -59.19% | 19.38M 31.03% |
| EBIT Q2Q % growth | 10.71M -62.96% | 15.3M 221.16% |
All data in NOK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.41 -353.86% | 0.50 | -0.91 | -182.35% |
| Q4 2024 Q2Q % growth | -0.70 -236.90% | 0.10 | -0.80 | -796.05% |
| Q3 2024 Q2Q % growth | 83.08% | 0.71 | % | |
| Q2 2024 Q2Q % growth | 1.15 228.76% | 0.93 | 0.22 | 23.46% |
| Q1 2024 Q2Q % growth | -0.09 -111.88% | 0.29 | -0.38 | -131.30% |
| Q4 2023 Q2Q % growth | -56.48% | 0.51 | % | |
| Q3 2023 Q2Q % growth | 0.39 1,174.51% | 0.32 | 0.07 | 23.34% |
| Q2 2023 Q2Q % growth | -0.89 | 0.20 | -1.09 | -547.46% |
| Q1 2023 Q2Q % growth | 0.77 | 0.43 | 0.33 | 76.70% |
| Q4 2022 Q2Q % growth | 1.17 | 0.48 | 0.69 | 141.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 132.024M 9.23% | 139.38M | -7.356M | -5.28% |
| Q4 2024 Q2Q % growth | 131.196M 4.70% | 133.77M | -2.574M | -1.92% |
| Q3 2024 Q2Q % growth | 123.062M -12.72% | 149.94M | -26.878M | -17.93% |
| Q2 2024 Q2Q % growth | 156.305M 26.09% | 151.42M | 4.885M | 3.23% |
| Q1 2024 Q2Q % growth | 120.873M -0.75% | 133.11M | -12.237M | -9.19% |
| Q4 2023 Q2Q % growth | 125.311M 8.06% | 136.68M | -11.369M | -8.32% |
| Q3 2023 Q2Q % growth | 140.999M 51.92% | 119.85M | 21.149M | 17.65% |
| Q2 2023 Q2Q % growth | 123.967M 12.33% | 125.46M | -1.493M | -1.19% |
| Q1 2023 Q2Q % growth | 121.787M 93.32% | 110.67M | 11.117M | 10.05% |
| Q4 2022 Q2Q % growth | 115.967M 28.62% | 114.75M | 1.217M | 1.06% |
| Q3 2022 Q2Q % growth | 92.811M 45.88% | 93.84M | -1.029M | -1.10% |
| Q2 2022 Q2Q % growth | 110.361M 67.18% | % | ||
| Q1 2022 Q2Q % growth | 62.996M 7.42% | % | ||
| Q4 2021 Q2Q % growth | 90.16M 63.03% | % | ||
| Q3 2021 Q2Q % growth | 63.62M 12.01% | % | ||
| Q2 2021 Q2Q % growth | 66.014M 56.67% | % | ||
| Q1 2021 Q2Q % growth | 58.644M 5.40% | % | ||
| Q4 2020 Q2Q % growth | 55.302M 17.01% | % | ||
| Q3 2020 Q2Q % growth | 56.799M 16.29% | % | ||
| Q2 2020 Q2Q % growth | 42.135M -10.77% | % | ||
| Q1 2020 Q2Q % growth | 55.642M 22.40% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.66% | -1.66% | 0% | 0% |
| Revenue | 0% | -1.34% | 0% | -0.78% |